Filter By Category
Archives
Share on -
ASOBAMAST
Generic Name: ASOBAMAST
ABSTRACT -
Asobamast is an investigational anti-allergic and anti-asthmatic small molecule associated with inhibition of IgE-mediated allergic responses. It has been evaluated mainly in preclinical or early clinical contexts for allergic airway disease. It is not a standard approved asthma medicine and should not be used in place of established controller or rescue therapy.
DOSAGE -
No current approved standardized dosage is established. Any use must follow a clinical protocol or specialist direction. It should not replace inhaled rescue bronchodilators, inhaled corticosteroids, or other approved asthma control medicines.
SIDE EFFECTS–
- Possible or reported side effects may include:
- Headache
- Nausea
- Dizziness
- Rash or itching
- Respiratory symptoms may persist or worsen if asthma is undertreated
- Laboratory abnormalities in research settings
- Unknown long-term safety
ALLERGIC REACTIONS -
Potential allergic reactions include rash, hives, swelling, bronchospasm, or anaphylaxis.
DRUG INTERACTIONS-
Use caution with:
- Other asthma controllers and biologics
- Systemic corticosteroids
- Antihistamines or leukotriene modifiers
- Investigational allergy medicines
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTIONS–
- Confirm asthma diagnosis and control status.
- Do not use for acute bronchospasm.
- Assess infection, pregnancy, liver/renal function, and concomitant medications if part of a study.
WARNINGS –
- Patients with asthma must have access to approved rescue therapy.
- Investigational status and limited safety data require medical supervision.
- Keep out of reach of children.
- In case of overdose, severe reaction, or clinical deterioration, seek immediate medical attention.
Share on -
. Developed by